Canaccord Genuity Group Increases KORU Medical Systems (NASDAQ:KRMD) Price Target to $4.00

KORU Medical Systems (NASDAQ:KRMD) had its price objective hoisted by Canaccord Genuity Group from $3.00 to $4.00 in a report issued on Thursday morning,Benzinga reports. They currently have a buy rating on the stock.

A number of other equities analysts also recently commented on KRMD. Piper Sandler boosted their price objective on KORU Medical Systems from $3.00 to $3.50 and gave the stock an “overweight” rating in a research report on Thursday. B. Riley assumed coverage on KORU Medical Systems in a report on Thursday, July 25th. They issued a “buy” rating and a $4.00 price target for the company.

KORU Medical Systems Trading Down 0.6 %

Shares of NASDAQ KRMD traded down $0.02 during trading on Thursday, hitting $3.06. 80,506 shares of the company were exchanged, compared to its average volume of 114,603. The firm has a market capitalization of $140.30 million, a PE ratio of -12.48 and a beta of 0.41. KORU Medical Systems has a 12-month low of $1.98 and a 12-month high of $3.40. The company has a fifty day moving average price of $2.65 and a 200-day moving average price of $2.47. The company has a debt-to-equity ratio of 0.01, a quick ratio of 3.27 and a current ratio of 3.77.

Institutional Investors Weigh In On KORU Medical Systems

Several hedge funds have recently modified their holdings of the stock. Lakewood Asset Management LLC grew its position in shares of KORU Medical Systems by 13.9% in the 2nd quarter. Lakewood Asset Management LLC now owns 68,225 shares of the company’s stock worth $181,000 after acquiring an additional 8,300 shares in the last quarter. Aaron Wealth Advisors LLC acquired a new position in KORU Medical Systems during the 2nd quarter valued at approximately $28,000. Allspring Global Investments Holdings LLC acquired a new position in KORU Medical Systems during the 2nd quarter valued at approximately $28,000. Legato Capital Management LLC bought a new stake in KORU Medical Systems during the 2nd quarter valued at $35,000. Finally, Virtu Financial LLC bought a new stake in KORU Medical Systems during the 1st quarter valued at $63,000. 58.60% of the stock is currently owned by hedge funds and other institutional investors.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.